Publications

30 Nov 2016
Op-Ed

Where Could More Regulation Help Small Businesses? Online Lending.

experience. Not to be outdone, incumbents like JPMorgan Chase and Wells Fargo are also moving into online lending, in some cases partnering with emergent fintech players. Taken together, Morgan Stanley estimates online lending to small... View Details

Keywords: by Karen Mills and Brayden McCarthy; Financial Services

01 Apr 2001
News

Tatsuyuki Saeki: Putting Stock in New Options at Nasdaq Japan

of the wildly successful American technology stock market. Launched last year as a joint venture between the U.S. Nasdaq, Japan’s Softbank Corporation, and thirteen leading Japanese and foreign brokerages, Nasdaq Japan aims to break the stranglehold of the dominant... View Details

Keywords: Alejandro Reyes; Securities, Commodities, and Other Financial Investments; Finance

February 2001
Case

Mavesa (B): International Strategy and Valuation Concerns

Examines Mavesa's response to economic liberalization. Looks at Mavesa's efforts to expand into neighboring countries. Also looks at efforts to support the firm's stock price. A rewritten version of an earlier case. View Details

Keywords: Multinational Firms and Management; Emerging Markets; Global Strategy

17 Oct 2019
News

Venturing Away from Venture Capital

Life Science Entrepreneurship in 2015, she worked for several venture capital firms specializing in health care and technology startups.) In order to satisfy the limited partners that supply their capital, Unger explains, venture... View Details

Keywords: Alexander Gelfand

16 Sep 2024
News

Life Preserver

“There’s a massive gap between how many people get to benefit from a lifesaving organ transplant and how many truly need one,” says Sebastian Giwa (MBA 2009). He’s spent the last decade trying to change that. In the United States alone, scientists estimate between... View Details

08 Jul 2002
Research & Ideas

How to Fashion Your New E-Business Model

flexibility were limited. The new e-business models emerging on the Internet can be classified within one or more of the generic market roles. In addition, the models can be grouped into two categories.... View Details

Keywords: by Lynda M. Applegate

19 Jan 2016
First Look

January 19, 2016

https://www.hbs.edu/faculty/Pages/item.aspx?num=50334 2016 Business History Business Groups, Entrepreneurship and the Growth of the Koç Group in Turkey By: Jones, Geoffrey, and Asli M. Colpan Abstract—This article examines the View Details

Keywords: Sean Silverthorne

2014
Article

Corporate Social Responsibility Reporting in China: Symbol or Substance?

By: Christopher Marquis and Cuili Qian

This study focuses on how and why firms strategically respond to government signals regarding appropriate corporate activity. We integrate institutional theory and research on corporate political strategy to develop a political dependence model that explains (a) how... View Details

Keywords: Institutional Theory; Political Strategy; Non-market Strategy; China; Corporate Social Responsibility; Corporate Disclosure; Corporate Social Responsibility and Impact; Emerging Markets; Government and Politics; China

September 2011
Case

China Development Bank

By: Li Jin, Matthew Preble and Aldo Sesia

In May 2011, Chairman Chen Yuan of the China Development Bank (CDB) was thinking back on CDB's financing of a major project between Petroleo Brasileiro SA (Petrobras), Brazil's state-owned oil and gas producer and China Petroleum & Chemical Corporation (Sinopec), one... View Details

Keywords: International Finance; Emerging Markets; Energy Sources; Banks and Banking; Energy Industry; Brazil; China

August 2010 (Revised January 2012)
Supplement

Leaders Who Make a Difference: Sam Palmisano's Smarter IBM: Day 2

By: Joseph L. Bower and Sonja Ellingson Hout

Sam Palmisano became CEO of IBM in 2002. He dramatically energized the organization through portfolio changes and a values driven approach to managing the company. View Details

Keywords: Transformation; Leadership; Leadership Style; Business or Company Management; Emerging Markets; Value

October 2009 (Revised July 2013)
Case

Gilead Sciences, Inc.: Access Program

By: V. Kasturi Rangan and Katharine Lee

Gilead Sciences, the U.S. leader in HIV/AIDS medicines, with global sales of $5.4 billion in 2009, had undertaken several innovative actions to make its anti-viral products available to over 100 low- and middle-income countries. Having reached nearly 680,000 patients... View Details

Keywords: Health Care and Treatment; Emerging Markets; Product; Sales; Competitive Strategy; Biotechnology Industry; Pharmaceutical Industry